With Pfizer’s Generic business Upjohn and Mylan Merger to occur in mid 2020, as an investor you may have some questions in mind, below I have answered couple of the common ones.


Details are gathered by emailing investor relations and using the information on Pfizer and Mylan’s website.

Common Questions –

What will be the name of new company after Mylan and UpJohn Merger ?

Mylan and Pfizer Announced Viatris as the New Company Name.

Viatris will have a new ticker symbol and its not disclosed yet.

Also no guidance yet if the stock will trade on NYSE:PFE or NASDAQ:MYL

Where Viatris stands in Generic Pharma’s business ?

Viatris stands at top in Generic Pharma based on expected sales and market value

Viatris stands at top in Generic Pharma based on expected sales and market value
Source: Investor Presentation – Sept. 2019

Per press release: It is expected that in the coming months, shareholders of Mylan will vote on the proposed merger of Mylan and Upjohn. More information regarding Viatris, including the company’s full executive management team, board of directors, stock symbol, and logo will be available at a later date.

Will Pfizer shareholders get Mylan stock ?

Pfizer Shareholders will get Viatris Stock. Ticker symbol not specified yet.

What amount of Viatris Shares will be issued per Pfizer Share ?

For each Pfizer Share you own you will receive 0.12 shares of Viatris.

Or in other words 12 shares per 100 Pfizer Shares.

Calculator to calculate – How many Viatris share you will receive ?

Enter the amount of Pfizer shares you own to know how many Viatris shares you will own.

Your Pfizer Shares:

Example: if you have 25 shares or 8976 shares the calculator will make your life easier.

Investor Presentations Summary

Skimming Most Valuable information on the Merger

Merger Summary

Mylan Upjohn merger summary
Source: Investor Presentation – July 2019

New Companies Financial Estimates

Viatris Financial Profile
Source: Investor Presentation – July 2019

Pharmaceutical Competitive Landscape

Pharmaceutical Competitive Landscape and where Viatris stands
Source: Investor Presentation – July 2019

Quick Links

Press Releases

Pfizer and Mylan Announce Two Future Viatris Board Members

About Mylan

Mylan is a global generic pharmaceutical company providing generic healthcare products. Offering a portfolio of over 7,500 marketed products around the world with presense in about 165 countries.


Investor Relations:

About Pfizer Upjohn

With over 130 years of experience, Pfizer Upjohn brings together 20 of the industry’s very recognised brands — products such as Lipitor, Norvasc, Lyrica and Viagra with manufacturing and commercial expertise in more than 120 countries.


Investor Relations:

Navjot is a Hobby Blogger from Ireland, and loves to create content to help people. He makes time on weekends to work on this blog. And has a full time position at Verizon Media as Technical Solutions Consultant, which he loves and thrives at. His Skills include in-depth knowledge of SEO, Javascript, Advertising, HTML and Java.